Tethis appoints Holger Neecke as the company`s Chief Executive Officer
After its parent company AGC Inc. acquired 100% of the shares of MolMed S.p.A. on September 30, 2020, AGC Biologics said that MolMed's entity name has been changed to AGC Biologics S.p.A.